Human decellularized extracellular matrix from adipose tissue is a permissive microenvironment for pancreatic organoids generation

This study demonstrates that a novel hydrogel derived from decellularized human adipose tissue (atdECM) provides a physiologically relevant, tissue-specific microenvironment that supports the generation of human pancreatic organoids with improved homeostatic transcriptional profiles compared to the standard Matrigel matrix.

The Gist

The Big Idea: Building Better "Homes" for Cells

Imagine you want to grow a tiny, 3D model of a human pancreas (a "pancreatic organoid") in a lab to test new drugs or study diseases. To do this, you need a scaffold—a soft, 3D structure for the cells to live on, grow, and organize themselves.

For years, scientists have used a "gold standard" material called Matrigel. Think of Matrigel as a pre-made, high-end apartment complex. It works great, but it has two big problems:

1. It's made from mice: It comes from mouse tumors, which isn't ideal for human medicine.
2. It's too "loud": It's packed with so many growth signals that it sometimes tricks the cells into acting stressed or inflamed, like living in a noisy, chaotic city.

The Solution: The researchers in this paper wanted to build a better apartment complex. They decided to use human fat tissue (adipose tissue) that is usually thrown away during surgery. They turned this fat into a new, custom-made scaffold called atdECM.

---

How They Made It: The "Fat-to-Fabric" Process

Making this new material was like turning a greasy, messy pile of old furniture into a clean, sturdy, and useful rug.

1. The Source: They took human fat tissue (from two donors).
2. The Cleaning (Decellularization): They washed the fat thoroughly to remove all the living cells and the actual fat droplets. Imagine scrubbing a sponge until it's completely empty of its original contents but keeps its shape.
3. The Result: What was left was the Extracellular Matrix (ECM). Think of the ECM as the "skeleton" or the "frame" of the tissue. It's made mostly of collagen (a protein that gives structure).
4. The Transformation: They turned this dried-out protein powder back into a jelly-like gel (hydrogel) that cells can live in.

The Comparison: The "Mouse Apartment" vs. The "Human Home"

The team tested their new human-made gel against the old mouse-made Matrigel. Here is what they found:

1. The Feel (Mechanics)

• Matrigel: It's quite stiff. Imagine trying to grow a plant in concrete. It's hard.
• atdECM: It has a softness that matches real human tissue (specifically, the softness of a healthy pancreas). It's like growing that plant in rich, soft soil.
• Why it matters: Cells can "feel" how stiff their environment is. If the environment is too hard, the cells get confused. The new gel feels just right to the cells.

2. The Ingredients (Biochemistry)

• Matrigel: It's a "super-stimulant." It's loaded with a chaotic mix of signals from a mouse tumor. It's like a party with too much music, too many lights, and too much caffeine. The cells get excited, but also stressed and inflamed.
• atdECM: It's a "balanced diet." Because it comes from human fat, it contains the specific proteins and signals that human cells are used to. It's quieter, more natural, and less likely to stress the cells out.

3. The Outcome: Growing Pancreas Organoids

They put human pancreatic cells into both gels to see what happened.

• The Look: In both gels, the cells grew into beautiful, round, 3D structures that looked like tiny pancreases. They looked almost identical under a microscope.
• The Inside Story (The Transcriptome): This is where the magic happened. The researchers looked at the cells' "instruction manuals" (their genes).
  • In Matrigel: The cells were acting stressed. Their genes were screaming, "We are under attack! We are inflamed!" (High levels of stress and inflammation genes).
  • In atdECM: The cells were calm and behaving naturally. Their genes said, "We are healthy, we are growing, and we are doing our job." (Low inflammation, high differentiation).

The Takeaway: Why This Matters

Think of the cells as actors in a play.

• When you put them in Matrigel, they are acting in a chaotic, noisy theater. They might still perform the play, but they are stressed and acting out of character because of the environment.
• When you put them in atdECM, they are in a quiet, natural setting. They can focus on their script and act exactly like real human cells.

Why is this a big deal?

1. Better Science: If you want to test a new drug for diabetes or cancer, you need cells that act like real human cells, not stressed-out cells. The new gel gives more accurate results.
2. Ethical & Safe: It uses human tissue (which is abundant and often wasted) instead of mouse tumors. This makes it safer for future human therapies.
3. The Future: This proves that we don't need to rely on animal products to grow human tissues. We can build "human homes" for our cells using materials we already have.

In short: The researchers turned human fat into a perfect, natural home for pancreatic cells. These cells are happier, calmer, and more "themselves" in this new home than they are in the old, noisy mouse-made home. This is a huge step forward for personalized medicine and drug testing.

Technical Summary

1. Problem Statement

• Limitations of Current Models: Organoid culture currently relies heavily on Matrigel, an animal-derived hydrogel extracted from murine sarcomas. While effective, Matrigel has significant drawbacks:
  • Non-physiological Origin: It is tumor-derived and species-specific (mouse), limiting its relevance for human disease modeling and regenerative medicine.
  • Batch Variability: Its complex, undefined composition leads to inconsistency between batches.
  • Biochemical Bias: It is highly enriched in pro-mitogenic and pro-inflammatory factors, which can induce stress responses and alter the physiological state of cultured cells.
• Need for Alternatives: There is a critical need for human-derived, tissue-specific extracellular matrix (ECM) hydrogels that recapitulate the native biochemical and biomechanical microenvironment without the immunogenicity or variability of animal products.
• Source Scarcity: While decellularized ECM (dECM) from various human tissues (liver, pancreas, etc.) is promising, obtaining these tissues is often difficult due to ethical constraints and limited availability. Adipose tissue is abundant, routinely discarded during surgery, and a sustainable source, but its utility for generating organoids (specifically pancreatic) requires validation.

2. Methodology

The study employed a multi-disciplinary approach combining tissue engineering, proteomics, biomechanics, and transcriptomics.

• atdECM Production:
  • Source: Fresh human subcutaneous adipose tissue from two female donors (BMI 28–29).
  • Process: A five-step protocol involving tissue fragmentation, osmotic shock, enzymatic digestion (Trypsin), homogenization, delipidation (Triton-X100/NH4OH), and sterilization.
  • Hydrogel Formation: The decellularized tissue was freeze-dried, cryo-milled into powder, solubilized in pepsin/HCl, and neutralized to form a self-gelling hydrogel at 37°C.
• Characterization:
  • Histology: DAPI (nuclei), AdipoRed (lipids), and PicroSirius Red (collagen) staining to verify decellularization and structural preservation.
  • Biomechanics: Atomic Force Microscopy (AFM) for ultrastructure and uniaxial compression testing to determine Young's modulus (stiffness).
  • Proteomics: Mass Spectrometry (LC-MS/MS) to identify matrisome proteins and compare composition with Matrigel.
  • Cytokine Profiling: Proteome Profiler arrays to quantify soluble bioactive factors (growth factors, cytokines, adipokines).
• Organoid Culture & Analysis:
  • Cell Line: Human pancreatic epithelial cells (H6C7).
  • Conditions: Cells were cultured in 3D on atdECM, Matrigel, and uncoated controls.
  • Phenotypic Analysis: Immunofluorescence for epithelial markers (Cytokeratin 14, E-Cadherin, Laminin α5, Collagen IV) and proliferation (Ki67).
  • Transcriptomics: Bulk RNA-sequencing (RNA-Seq) followed by differential gene expression analysis (DESeq2) and Gene Set Enrichment Analysis (GSEA) to compare transcriptional profiles across conditions.

3. Key Contributions

• Protocol Development: Established a robust, reproducible protocol for generating a self-gelling hydrogel from human adipose tissue that effectively removes cellular/lipid components while preserving ECM architecture.
• Comprehensive Characterization: Provided a deep molecular and mechanical profile of human adipose-derived ECM (atdECM), contrasting it directly with the gold-standard Matrigel.
• Transcriptomic Insight: Demonstrated that while morphological outcomes may appear similar, the transcriptional landscape of organoids is heavily influenced by the matrix, revealing that Matrigel induces a stress/inflammatory state not present in atdECM cultures.

4. Key Results

• Decellularization Efficiency:
  • Histology confirmed near-complete removal of nuclei and lipids.
  • Collagen architecture (Type I and IV) was preserved, with a yield of ~1g powder per 100g tissue.
• Biomechanical Properties:
  • Stiffness: atdECM exhibited a Young's modulus of ~1.9–2.7 kPa, closely matching native human adipose and healthy pancreatic tissue.
  • Comparison: Matrigel was significantly stiffer (~6.2 kPa), approximately three times stiffer than atdECM and native tissue.
• Biochemical Composition:
  • Proteomics: atdECM was overwhelmingly collagen-rich (99.95% of matrisome proteins), dominated by Type I and III collagens. In contrast, Matrigel was heterogeneous, rich in basement membrane proteins (laminins, nidogens) but poor in fibrillar collagen.
  • Cytokines: atdECM retained a balanced profile of adipokines (adiponectin, leptin) and growth factors. Matrigel showed a strong enrichment in pro-angiogenic, mitogenic, and pro-inflammatory factors (VEGF, MMPs, Serpin E1).
• Organoid Generation:
  • Morphology: atdECM successfully supported the formation of pancreatic organoids with acinar-like hollow structures, comparable in size, shape, and polarity to those grown in Matrigel.
  • Viability: Organoids expressed key epithelial markers (K14, Laminin α5, Collagen IV) and showed comparable proliferation rates (Ki67) in both matrices.
• Transcriptomic Differences (The Critical Finding):
  • Inflammation: Organoids in Matrigel showed significant upregulation of inflammatory pathways (Interferon-α/γ, KRAS signaling, acute-phase response genes like SAA1/2).
  • Physiology: Organoids in atdECM displayed a profile closer to physiological epithelial homeostasis. They showed:
    • Downregulation of stress/inflammatory markers (SAA1, SAA2, KRT23).
    • Upregulation of differentiation and adhesion markers (KRT10, CDH13, ITGAE).
    • Enrichment in pathways related to controlled proliferation (G2M checkpoint, E2F targets) and oxidative phosphorylation.

5. Significance

• Physiological Relevance: This study proves that human-derived atdECM provides a more physiologically accurate microenvironment than Matrigel. It supports organoid growth while minimizing the artificial stress and inflammatory responses induced by tumor-derived matrices.
• Translational Potential: As a human-derived, abundant, and ethically accessible material, atdECM is a superior candidate for regenerative medicine, personalized drug screening, and disease modeling where human-specific responses are critical.
• Paradigm Shift: The findings suggest that while cells can self-organize into similar morphologies in different matrices, the transcriptional state of the resulting tissue is matrix-dependent. Using atdECM allows researchers to study "true" human tissue biology without the confounding variables of animal-derived, pro-inflammatory scaffolds.
• Scalability: The use of adipose tissue addresses the supply chain limitations of other human tissues, offering a scalable platform for future organoid applications.